![]()
Pharmaceutical giant AstraZeneca’s agreement to sell much of its antibiotics business won’t impact operations at MedImmune, its Gaithersburg-based research and development arm, officials confirmed Wednesday.
![]()
Pharmaceutical giant AstraZeneca’s agreement to sell much of its antibiotics business won’t impact operations at MedImmune, its Gaithersburg-based research and development arm, officials confirmed Wednesday.

Before we start, long time readers know, we have no interest in trying to influence your political views or voting allegiance (not that we could). So please don’t look for “hidden meanings” or agendas. If we have something to convey, we will come right out and say it.
We could have done several SBIR Insiders over the eight weeks, but none of them would have had much value because every time I thought we had something important to report, the story would change and the relevance of the Insider issue would have been moot.

Tans are fading, school is starting, football is about to take over our televisions, and the MCEDC is gearing up. It’s time to bring you up to date with the current roster of all-stars:

Steve Klasko, president of Thomas Jefferson University and CEO of Jefferson Health, is the author of We Can Fix Healthcare: The Future Is Now, with Wharton adjunct professor Gregory P. Shea and Michael Hoad. In the book, the authors propose 12 disruptive transformations to the health care industry.
Klasko stopped by the Knowledge@Wharton Show on Sirius XM channel 111 with Nishad Rahman, a medical student at Jefferson, to talk about this changing industry.

In an ongoing effort to improve the experience of doing business in and/or with Montgomery County, County Executive Ike Leggett is inviting the business community to identify opportunities for streamlining and simplifying rules and regulations for businesses, and for improving the County government’s services to businesses. Your anonymous and confidential feedback will help us identify areas where change will have a positive impact. Thank you for participating.
![]()
Pharmaceutical giant AstraZeneca’s agreement to sell much of its antibiotics business won’t impact operations at MedImmune, its Gaithersburg-based research and development arm, officials confirmed Wednesday.

More and more big firms are bringing young talent in-house in the hope that they will bring fresh ideas along with them and infuse new vigor into their companies. German pharma giant Bayer is also following this trend.

Health systems in developed countries face a twofold challenge: ensuring financial sustainability and improving quality. Digitization can help health systems achieve both these objectives and unlock substantial value through lower spending and superior healthcare delivery.

After decades of inconclusive results, researchers backed by Pfizer and Massachusetts General Hospital revealed that they had identified several genetic markers associated with depression earlier this month. It was the largest study of its kind, using data from more than 120,000 people.

Twenty accomplished female life sciences executives will comprise the first ever cohort of Women In Bio’s Boardroom Ready program, the organization announced today. The women will spend five days this fall at George Washington University completing a new executive-level board certification training program to prepare them to join corporate Boards of Directors.